Green tea polysaccharide conjugates and bovine serum albumin have a synergistic effect in improving the emulsification ability.

Our previous study revealed that green tea polysaccharide conjugate (gTPC) has emulsion effect, but its emulsifying ability is weak. In order to improve the emulsification ability of gTPC, gTPC and bovine serum albumin (BSA) were combined to form five different mass proportions of the TPC/BSA (TB) complex: TPC/BSA: 5:1, 5:2, 5:3, 5:4, and 5:5 w/w. We observed that the 5:5 w/w TB emulsion was more hydrophobic and surface-active. Furthermore, the emulsions prepared using 50.00 wt% medium-chain triglycerides exhibited the best stability. In addition, the TB emulsion exhibited stability in adverse environments of pH, salt, and heat; in particular, under salt conditions, no significant changes were observed in zeta potential. Subsequently, in vitro simulated digestion experiments were performed to investigate the use of TB emulsions for ß-carotene encapsulation. We observed that the encapsulation efficiency for ß-carotene was approximately 90.0 %; it was subsequently released in the intestine.

Regulating effects of phytosterol esters-loaded emulsions stabilized with green tea polysaccharide conjugates and Tween on lipids in KKAy mice.

Phytosterol esters (PSE) have been shown to have cholesterol-lowering effects, but their insolubility in water limits their applications. Green tea polysaccharide conjugates (gTPC) have hypoglycemic and emulsifying effects. To address lipid dysregulation in diabetic patients, we developed PSE-loaded emulsions stabilized with gTPC and Tween-20 (gTPC-PSE emulsions) and evaluated their physicochemical properties. We subsequently investigated the lipid-regulating potential of these emulsions to in KKAy mice. The KKAy mice were randomly assigned to eight groups: the model group, the Lipitor (10 mg·kg-1)-acarbose (30 mg·kg-1) combination group, two gTPC groups, two PSE groups, and two gTPC-PSE groups with a 1:2 mass ratio of gTPC to PSE. The administered doses were 90 and 270 mg kg-1, respectively. Administration of a 270 mg·kg-1 dose of gTPC-PSE emulsions led to the most significant effects including increased levels of liver and serum high-density lipoprotein cholesterol (HDL-CH), reduced serum leptin and insulin, and improved liver superoxide dismutase (SOD) and reduced malondialdehyde (MDA). In general, gTPC and PSE demonstrated a synergistic effect on lipid regulation in mice. Our results indicate that gTPC-PSE emulsions hold potential as a nutritional intervention for diabetes by modulating lipid levels.